Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Arzneimittel-Forschung|February 1, 1994
Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypesA Czyrak, G Skuza, Z Rogóz, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's diseaseJ Maj, Z Rogóz, G Skuza, et al.Polish Journal of Pharmacology and Pharmacy|January 1, 1981
Influence of proadifen, an inhibitor of the metabolism of drugs, on the action of imipramine and desipramine in ratsJ Maj, W Daniel, Z Rogóz, et al.Polish Journal of Pharmacology and Pharmacy|November 1, 1982
The effect of proadifen, a drug metabolism inhibitor, on action of imipramine and desipramine in miceJ Maj, M Melzacka, Z Rogóz, et al.Pharmacopsychiatria|November 1, 1982
Central action of amitriptyline N-oxideJ Maj, J Vetulani, J Michaluk, et al.Polish Journal of Pharmacology and Pharmacy|July 1, 1978
The influence of neuroleptics on the behavioural effect of 5-hydroxytryptophanJ Maj, L Baran, K Bigajska, et al.Polish Journal of Pharmacology|September 1, 1993
Central effects of repeated treatment with CGP 37849, a competitive NMDA receptor antagonist with potential antidepressant activityJ Maj, V Klimek, K Gołembiowska, et al.Polish Journal of Pharmacology and Pharmacy|September 1, 1989
Antidepressant activities of WEB 1881, a new nootropic agentJ Maj, Z Rogóz, G Skuza, et al.Neuropharmacology|August 28, 2001
Effect of repeated treatment with tianeptine and fluoxetine on the central alpha(1)-adrenergic systemZ Rogóz, G Skuza, D Dlaboga, et al.European Journal of Pharmacology|May 23, 1996
Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brainJ Maj, M Dziedzicka-Wasylewska, R Rogoz, et al.Pageof 8